LGALS3 and complication: It was confirmed by our results that the level of GAL-3 in patients with cardiovascular complications was significantly higher than those in the control group, with a statistically significant difference (P=0.00), while the level of Klotho was significantly lower than those without cardiovascular complications, with a statistically significant difference (P=0.00).